Table 2. Clinical characteristics of incident patients with systemic lupus erythematosus (SLE n=45) and Cutaneous Lupus Erythematosus (CLE, n=62).
| SLE Number (Percentage, %) |
CLE Number (Percentage, %) |
||
|---|---|---|---|
| Age, years (mean ± SD) | 42.0 ± 17.9 | 47.6± 16.9 | |
| Sex, female | 41 (91) | 45 (73) | |
| Follow up, years (mean ± SD) | 7.8 ± 4.9 | 10.0 ± 6.0 | |
| Race | |||
| White | 36 (80) | 44 (71) | |
| Asian | 3 (7) | 2 (3) | |
| African American | 2 (4) | 4 (6) | |
| Other | 1 (2) | 4 (6) | |
| Unknown | 3 (7) | 8 (13) | |
| ACR Criteria | Subtypes of CLE | ||
| Malar rash | 14 (31) | Discoid Lupus | |
| Discoid rash | 3 (7) | Localized | 34 (55) |
| Photosensitivity | 23 (51) | Generalized | 12 (19) |
| Oral ulcers | 12 (27) | SCLE | |
| Arthritis | 32 (71) | - Annular/Polycyclic | 5 (8) |
| Serositis | 12 (27) | - Psoriasiform | 8 (13) |
| Renal (Cellular casts and or | 12 (27) | ||
| proteinuria) | 24 (53) | Lupus Panniculitis | 2 (3) |
| Hematologic disorder* | 5 (11) | Bullous LE | 1 (2) |
| Hemolytic anemia | 15 (33) | ||
| Leukopenia | 9 (20) | ||
| Lymphopenia | 11(24) | ||
| Thrombocytopenia | 3 (7) | ||
| Psychosis/seizure | 33(73) | ||
| Immunologic Disorder | |||
| Positive ANA | 45 (100) | 32 (52) | |
| Positive dsDNA | 29 (64) | 1 (2) | |
| anti- Smith (Sm) | 4 (9) | Not available | |
| Anticardiolipin (aCL) | 10 (22) | Not available |
*
Total number exceeds patient number as many patients had simultaneous prevalence of various cytopenias